Searched for
GLOBAL HEALTH TARGET PRICE
'Cheaper than a gym, but still not selling': Nithin Kamath on why Indians aren't embracing popular weight-loss drugsDespite rising obesity and affordable generic GLP-1 drugs, India lags in adoption. Nithin Kamath highlights patient retention challenges wi...- HDFC Mutual Fund buys additional 10 lakh shares of Global Health for Rs 130 croreHDFC Mutual Fund has secured an additional 10 lakh shares of Global Health, which is known for operating Medanta hospitals, from co-founder...
- Payoneer India Cross-Border Excellence Awards 2026: From fashion to wellness, spotlighting India's e-commerce export championsThe Payoneer India Cross-Border Excellence Awards 2026 celebrate India's rising exporters, spotlighting e-commerce leaders in fashion, home...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsIt is probably time to be bullish as an investor. But remember two things. One: Valuations are still not cheap. Two: Because it is over and...
- Capex boom, global sourcing tailwinds fuel textile stock rallyTextile exporter stocks witnessed a significant rally on Wednesday, boosted by positive initiation of coverage from Motilal Oswal Financial...
- RBI remains watchful of global, monsoon situation says Sanjay MalhotraThe Reserve Bank of India is adopting a cautious "wait and watch" approach regarding global geopolitical shifts and monsoon progress. Gover...
- ‘It's a big price tag’: Bryan Johnson explains why international travel affects sleep, cortisol and overall health, tech millionaire says it takes "two weeks to recover"Tech millionaire Bryan Johnson advocates for limiting international travel to once every three months, citing a significant biological cost...
- Online: Two-thirds of Indians (66%) have encountered a health or wellness scam: McAfee Health & Wellness researchNew research from McAfee reveals a surge in health scams targeting Indians, particularly young adults. Scammers are exploiting influencer t...
- Tata Motors shares jump 5% on strong growth guidance. What are Nomura, other brokerages saying?Tata Motors shares rose after outlining strong growth targets, including margin expansion and cash flow improvement. Brokerages remain divi...
- Global markets | Australian shares rise modestly as sticky core inflation keeps rate hike bets aliveAustralian shares edged higher on Wednesday, a cautious advance following inflation data. While headline inflation eased, core inflation ti...
- Motilal Oswal initiates coverage on KPR Mill, 7 other textile stocks with up to 43% upside. Own any?Motilal Oswal has initiated coverage on eight textile companies, turning bullish on Gokaldas Exports, Indo Count, Arvind Fashions, Pearl Gl...
- Need to cut chemical fertilisers usage via crop diversification, incentives: EAC-PM ChairmanIndia must curb chemical fertilizer use by promoting crop diversification, natural farming, and productivity-linked incentives, stated EAC-...
- Beyond Jio IPO: 5 triggers Mukesh Ambani has lined up to revive Reliance shares for 44 lakh investorsReliance Industries is charting a new course to boost its stock for 44 lakh investors, moving beyond a potential Jio IPO. Billionaire Mukes...
- Should investors buy the dip in Vedanta shares after 9% slide? Analysts weigh inVedanta shares fell on Tuesday after promoter entity Twin Star Holdings reportedly sold around 7.3 crore shares (1.7% stake) worth ₹2,149 c...
- US stocks: Miner Sinda kicks off US IPO roadshow with $1.97 billion valuation targetSilver miner Sinda has launched its US IPO, aiming for a valuation up to $1.97 billion and seeking to raise $235.2 million. This debut adds...
- Indonesia plans to embed AI in key programmes, including $15 billion free-meal drive, document showsIndonesia's progress on AI has been slow when compared with Singapore and Malaysia. They are pushing to establish themselves as developme...
- Sell or Hold: Citi maintains buy on Cipla; Motilal Oswal recommends buy on RIL post AGMBrokerages remain bullish on Cipla and Reliance Industries, citing strong growth drivers and attractive valuations. Citi highlights regulat...
- US probes Germany's drug pricing policies, opens door to tariffsThe US has launched a trade probe into Germany's pharmaceutical pricing, alleging it unfairly burdens American commerce and forces the US t...
- Alembic Pharma gets tentative nod from USFDA for generic cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...
- HPV vaccination drive reaches 50 lakh girls in three monthsIndia's free Human Papillomavirus vaccination drive is making significant progress. Nearly 50 lakh doses of the cervical cancer vaccine hav...
Load More
